Holger Bang

5.9k total citations · 1 hit paper
65 papers, 3.3k citations indexed

About

Holger Bang is a scholar working on Molecular Biology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Holger Bang has authored 65 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Rheumatology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Holger Bang's work include Rheumatoid Arthritis Research and Therapies (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Signaling Pathways in Disease (17 papers). Holger Bang is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Signaling Pathways in Disease (17 papers). Holger Bang collaborates with scholars based in Germany, Netherlands and Austria. Holger Bang's co-authors include Gunter Fischer, Kay Brune, Mohamed A. Marahiel, Georg Schett, Gerald Willimsky, G. Fischer, Edith Berger, René E. M. Toes, Andreas Pahl and Eugen Feist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Holger Bang

65 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

2012 544 citations Holger Bang, Aline Bözec et al. profile →

Peers

Countries citing papers authored by Holger Bang

Since Specialization

Citations

This map shows the geographic impact of Holger Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Bang more than expected).

Fields of papers citing papers by Holger Bang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Bang. The network helps show where Holger Bang may publish in the future.

Co-authorship network of co-authors of Holger Bang

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Bang. A scholar is included among the top collaborators of Holger Bang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Bang. Holger Bang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review) 2024 ·Oncology Letters ·Ju‐Yeon Kim, Holger Bang, (unknown), Eun‐Sook Kim, (unknown)	3
2	Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk 2023 ·RMD Open ·Maria Sokolova, F Hartmann, Daniela Sieghart, Holger Bang, G Steiner, Arnd Kleyer, Georg Schett, Ulrike Steffen	8
3	The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis 2022 ·Lara D. Veeken ·Helga Westerlind, Alf Kastbom, Johan Rönnelid, Monika Hansson, Lars Alfredsson, Linda Mathsson‐Alm, Guy Serre, Martin Cornillet, Rikard Holmdahl, Karl Skriner, Holger Bang, Lars Klareskog, Saedís Saevarsdóttir, Karin Lundberg, Caroline Grönwall, Johan Askling	4
4	Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies 2020 ·Scientific Reports ·(unknown), Holger Bang, (unknown), Laura Nuño, (unknown), Diana Peiteado, Ana M. Ortiz, Alejandro Villalba, Ana Martínez‐Feito, Alejandro Balsa, Isidoro González‐Álvaro, Antonio González	10
5	Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications 2020 ·Annals of the Rheumatic Diseases ·Theresa Kissel, (unknown), (unknown), Marco Cavallari, (unknown), (unknown), Gerrie Stoeken‐Rijsbergen, (unknown), (unknown), (unknown), Jan W. Drijfhout, Holger Bang, (unknown), (unknown), Peter A. van Veelen, T. Huizinga, Hans Ulrich Scherer, Michael Reth, René E. M. Toes	80
6	The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study 2019 ·Nutrients ·(unknown), Holger Bang, Melanie Hagen, Michael Frech, (unknown), Maria Sokolova, Ulrike Steffen, Koray Taşçılar, Kerstin Sarter, Georg Schett, Jürgen Rech, Mario M. Zaiss	100
7	In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response 2019 ·Arthritis Research & Therapy ·Emma C. de Moel, V. Derksen, Leendert A. Trouw, Holger Bang, (unknown), Leroy R. Lard, Sofía Ramiro, T. Huizinga, Cornelia F Allaart, René E. M. Toes, Diane van der Woude	45
8	Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification 2019 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Mikhail Volkov, Annemarie L Dorjée, Lise Hafkenscheid, (unknown), (unknown), Theresa Kissel, (unknown), George M. C. Janssen, Peter A. van Veelen, Holger Bang, T. Huizinga, Leendert A. Trouw, Diane van der Woude, René E. M. Toes	40
9	Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner 2018 ·Arthritis Research & Therapy ·Aline Bözec, Yubin Luo, Cecilia Engdahl, Camille P. Figueiredo, Holger Bang, Georg Schett	43
10	Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes 2018 ·Arthritis Research & Therapy ·Emma C. de Moel, V. Derksen, (unknown), Leendert A. Trouw, Holger Bang, Robbert J Goekoop, I. Speyer, T. Huizinga, Cornelia F Allaart, René E. M. Toes, Diane van der Woude	37
11	Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis 2017 ·Annals of the Rheumatic Diseases ·Caroline Ospelt, Holger Bang, Eugen Feist, Giovanni G. Camici, Stephan Sylvest Keller, J. Detert, (unknown), Steffen Gay, (unknown), Gerd R Burmester	59
12	Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis 2015 ·Annals of the Rheumatic Diseases ·Maria Juárez, Holger Bang, (unknown), Ulf Reimer, (unknown), Ilfita Sahbudin, Christopher D. Buckley, Benjamin A. Fisher, Andrew Filer, Karim Raza	121
13	New Assay Generation for Antibodies Against Modified and Citrullinated Peptides Predicts Poor Response to TNF Inhibitor Therapy 2011 ·Arthritis & Rheumatism ·Lotta Ljung, Karl Egerer, Holger Bang, Eugen Feist, Gerd R Burmester, Solbritt Rantapää‐Dahlqvist	1
14	Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer 2008 ·European Urology ·Jens Köllermann, Thorsten Schlomm, Holger Bang, Gerhard Schwall, Christoph von Eichel‐Streiber, Ronald Simon, Martin Schostak, Hartwig Huland, (unknown), Guido Sauter, Helmut Klocker, André Schrattenholz	80
15	Recognition of protein substrates by the prolyl isomerase trigger factor is independent of proline residues 1 1Edited by P. E. Wright 1998 ·Journal of Molecular Biology ·Christian Schölz, (unknown), Michael Rapé, Michael Pecht, Andreas Pahl, Holger Bang, Franz X. Schmid	36
16	Weak Inhibitors of Cyclooxygenases May Exert Their Antinociceptive Effect by Modulation of Transcription Factors 1997 ·Advances in experimental medicine and biology ·(unknown), Holger Bang, Tino Münster, Kay Brune, Andreas Pahl	4
17	Cloning and characterization of ppiB, a Bacillus subtilis gene which encodes a cyclosporine A‐sensitive peptidyl‐prolyl cis‐trans isomerase 1994 ·Molecular Microbiology ·Michael Herrler, Holger Bang, Mohamed A. Marahiel	25
18	Interleukin-8 is a Cyclosporin A binding protein 1993 ·Cellular and Molecular Life Sciences ·Holger Bang, Kay Brune, (unknown), Ulrich Feige	14
19	Mip protein of Legionella pneumophila exhibits peptidyl‐prolyl‐cis/trans isomerase (PPIase) activity 1992 ·Molecular Microbiology ·Günter Fischer, Holger Bang, Birgit Ludwig, Karlheinz Mann, J. Häcker	148
20	Peptidyl‐prolyl cis‐trans isomerase from Bacillus subtilis A prokaryotic enzyme that is highly sensitive to cyclosporin A 1992 ·FEBS Letters ·Michael Herrler, Holger Bang, Kay Brune, Gunter Fischer, Mohamed A. Marahiel	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact